Dermatomyositis Terminated Phase 2 Trials for Siponimod (DB12371)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01148810Efficacy and Tolerability of BAF312 in Patients With Polymyositis and DermatomyositisTreatment